Picture of RadNet logo

RDNT — RadNet News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

RadNet Q4 revenue rises, adjusted EPS beats estimates

Overview

Diagnostic imaging provider's Q4 revenue rose 14.8% yr/yr to $547.7 mln

Adjusted EPS for Q4 beat analyst expectations

Company anticipates 2026 revenue growth of 17%-19% in Imaging Center segment

Outlook

RadNet anticipates 2026 Imaging Center revenue growth of 17%-19%

Company expects 2026 Digital Health revenue to grow 46%-56%

RadNet sees 2026 Free Cash Flow growth of 29%-41%

Result Drivers

PROCEDURAL VOLUME GROWTH - Aggregate advanced imaging procedural volumes increased 14.1% in Q4 2025, with same-center volumes up 9.6%

DIGITAL HEALTH GROWTH - Digital Health segment revenue rose 48.2% in Q4 2025, driven by AI solutions and acquisitions

OPERATIONAL EFFICIENCIES - Focus on operational efficiencies and AI technology implementation contributed to margin improvement

Company press release: ID:nGNXb4s6tJ

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 Revenue$547.70 mln
Q4 Adjusted EPSBeat$0.23$0.20 (7 Analysts)
Q4 EPS-$0.01
Q4 Net Income-$600,000
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the healthcare facilities & services peer group is "buy" Wall Street's median 12-month price target for RadNet Inc is $91.50, about 31.1% above its February 27 closing price of $69.81 The stock recently traded at 90 times the next 12-month earnings vs. a P/E of 110 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on RadNet

See all news